Approaches to decrease the prevalence of depression in later life

Current Opinion in Psychiatry

Volumn 25, Issue 6, 2012, Pages 451-456

  Almeida, Osvaldo P ^a,b,c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Depression; Elderly; Prevention; Risk factors; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; CYANOCOBALAMIN; FOLIC ACID; VITAMIN;

ANALGESIA; ANXIETY DISORDER; DEMOGRAPHY; DEPRESSION; DISEASE SEVERITY; HUMAN; LIFESTYLE; MENTAL HEALTH; NUTRITION; PATIENT CARE; PHYSICAL ACTIVITY; PSYCHOTHERAPY; PUBLIC-PRIVATE PARTNERSHIP; REVIEW; RISK ASSESSMENT; RISK FACTOR; SOCIAL STATUS; TREATMENT RESPONSE;

AGE FACTORS; AGE OF ONSET; AGED; ANTIDEPRESSIVE AGENTS; DEPRESSION; DEPRESSIVE DISORDER; HUMANS; PREVALENCE; PSYCHOTHERAPY; RISK ASSESSMENT; RISK FACTORS;

EID: 84867328462     PISSN: 09517367     EISSN: 14736578     Source Type: Journal    
DOI: 10.1097/YCO.0b013e328356bd57     Document Type: Review

References (46)

1. Beekman AT, Copeland JR, Prince MJ. Review of community prevalence of depression in later life. Br J Psychiatry 1999; 174:307-311. (Pubitemid 29179713)
2. Prince M, Patel V, Saxena S, et al. No health without mental health. Lancet 2007; 370:859-877. (Pubitemid 47371145)
3. Mathers C, Boerma T, Fat DM. The global burden of disease: 2004 update. Geneva: World Health Organization; 2008.
4. Akincigil A, Olfson M, Siegel M, et al. Racial and ethnic disparities in depression care in community-dwelling elderly in the United States. Am J Public Health 2012; 102:319-328.
5. Andrews G, Sanderson K, Slade T, Issakidis C. Why does the burden of disease persist? Relating the burden of anxiety and depression to effectiveness of treatment. Bull World Health Organ 2000; 78:446-454. (Pubitemid 30367598)
6. Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and accept-ability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 2009; 373:746-758.
7. Cuijpers P, van Straten A, Warmerdam L, Andersson G. Psychotherapy versus the combination of psychotherapy and pharmacotherapy in the treat-ment of depression: a meta-analysis. Depress Anxiety 2009; 26:279-288.
8. Kirsch I, Deacon BJ, Huedo-Medina TB, etal. Initial severity and antidepres-sant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLo S Med 2008; 5:e45.
9. Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965; 58:295-300.
10. Lyness JM, Yu Q, Tang W, et al. Risks for depression onset in primary care elderly patients: potential targets for preventive interventions. Am J Psychiatry 2009; 166:1375-1383.
11. Sriwattanakomen R, Ford AF, Thomas SB, etal. Preventing depression in later life: translation from concept to experimental design and implementation. Am J Geriatr Psychiatry 2008; 16:460-468.
12. Van't Veer-Tazelaar PJ, van Marwijk HW, van Oppen P, et al. Stepped-care prevention of anxiety and depression in late life: a randomized controlled trial. Arch Gen Psychiatry 2009; 66:297-304.
13. Walker JG, Mackinnon AJ, Batterham P, et al. Mental health literacy, folic acid and vitamin B12, and physical activity for the prevention of depression in older adults: randomised controlled trial. Br J Psychiatry 2010; 197:45-54.
14. Hackett ML, Anderson CS, House AO, Halteh C. Interventions for preventing depression after stroke. Stroke 2009; 40:e485-e486.
15. Robinson RG, Jorge RE, Moser DJ, et al. Escitalopram and problem-solving therapy for prevention ofpoststroke depression: arandomized controlled trial. JAMA 2008; 299:2391 -2400. (Pubitemid 351749237)
16. Almeida OP, Waterreus A, Hankey GJ. Preventing depression after stroke: results from a randomized placebo-controlled trial. J Clin Psychiatry 2006; 67:1104-1109. (Pubitemid 44230882)
17. Almeida OP, Marsh K, Alfonso H, et al. B-vitamins reduce the long-term risk of depression afterstroke:the VITATOPS-DEPtrial.Ann Neurol 2010; 68:503-510.
18. Munoz RF, Cuijpers P,Smit F, etal. Prevention of major depression.Annu Rev Clin Psychol 2010; 6:181-212.
19. Kessler D, Lloyd K, Lewis G, Gray DP. Cross sectional study of symptom attribution and recognition of depression and anxiety in primary care. BMJ 1999; 318:436-439.
20. Pfaff JJ, Almeida OP. A cross-sectional analysis of factors that influence the detection of depression in older primary care patients. Aust N Z J Psychiatry 2005; 39:262-265. (Pubitemid 40601665)
21. Arroll B, Elley CR, Fishman T, et al. Antidepressants versus placebo for depression in primary care. Cochrane Database Syst Rev 2009; CD007954.
22. Rush AJ, Trivedi MH, Wisniewski SR, etal. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006; 163:1905-1917. (Pubitemid 44807782)
23. Fournier JC, De Rubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA 2010; 303:47-53.
24. Corey-Lisle PK, Nash R, Stang P, Swindle R. Response, partial response, and nonresponse in primary care treatment of depression. Arch Intern Med 2004; 164:1197-1204. (Pubitemid 39030356)
25. Gilbody S, Sheldon T, House A. Screening and case-finding instruments for depression: a meta-analysis. CMAJ 2008; 178:997-1003. (Pubitemid 351533189)
26. Nelson JC, Delucchi K, Schneider LS. Efficacy of second generation anti-depressants in late-life depression: a meta-analysis of the evidence. Am J Geriatr Psychiatry 2008; 16:558-567.
27. Tedeschini E, Levkovitz Y, Iovieno N, etal. Efficacy ofantidepressantsforlate-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials. J Clin Psychiatry 2011; 72:1660-1668.
28. Wilson K, Mottram P. A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta-analysis. Int J Geriatr Psychiatry 2004; 19:754-762. (Pubitemid 39149252)
29. Mittmann N, Herrmann N, Einarson TR, et al. The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis. J Affect Disord 1997; 46:191 -217. (Pubitemid 28165944)
30. Wilson KC, Mottram PG, Vassilas CA. Psychotherapeutic treatments for older depressed people. Cochrane Database Syst Rev 2008; CD004853.
31. Cuijpers P, Geraedts AS, van Oppen P, etal. Interpersonal psychotherapy for depression: a meta-analysis. Am J Psychiatry 2011; 168:581 -592.
32. Reynolds CF, 3rd, Dew MA, Martire LM, et al. Treating depression to remission in older adults: a controlled evaluation of combined escitalopram with interpersonal psychotherapy versus escitalopram with depression care management. Int J Geriatr Psychiatry 2010; 25:1134-1141.
33. Reynolds CF, 3rd, Frank E, Perel JM, et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. JAMA 1999; 281:39-45. (Pubitemid 29025098)
34. Forsman AK, Schierenbeck I, Wahlbeck K. Psychosocial interventionsforthe prevention of depression in olderadults: systematic reviewand meta-analysis. J Aging Health 2011; 23:387-416.
35. Kho KH, van Vreeswijk MF, Simpson S, Zwinderman AH. A meta-analysis of electroconvulsive therapy efficacy in depression. J ECT 2003; 19:139-147. (Pubitemid 37087760)
36. Flint AJ, Gagnon N. Effective use of electroconvulsive therapy in late-life depression. Can J Psychiatry 2002; 47:734-741. (Pubitemid 35345717)
37. Kok RM, Heeren TJ, Nolen WA. Continuing treatment of depression in the elderly: a systematic review and meta-analysis of double-blinded randomized controlledtrialswithantidepressants. Am J Geriatr Psychiatry2011; 19:249-255.
38. Unutzer J, Katon W, Callahan CM, et al. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA 2002; 288:2836-2845. (Pubitemid 35425069)
39. Hunkeler EM, Katon W, Tang L, et al. Long term outcomes from the IMPACT randomised trial for depressed elderly patients in primary care. BMJ 2006; 332:259-263.
40. Bruce ML, Ten Have TR, Reynolds CF, 3rd, et al. Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial. JAMA 2004; 291:1081 -1091. (Pubitemid 38541685)
41. Van't Veer-Tazelaar PJ, van Marwijk HW, van Oppen P, et al. Prevention of late-life anxiety and depression has sustained effects over 24 months: a pragmatic randomized trial. Am J Geriatr Psychiatry 2011; 19:230-239.
42. Katon WJ, Lin EH, Von Korff M, et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med 2010; 363:2611 -2620.
43. Schoenbaum M, Unutzer J, Sherbourne C, et al. Cost-effectiveness of practice-initiated quality improvementfordepression: results of a randomized controlled trial. JAMA 2001; 286:1325-1330. (Pubitemid 33015523)
44. Gilbody S, Bower P, Whitty P. Costs and consequences of enhanced primary care for depression: systematic review of randomised economic evaluations. Br J Psychiatry 2006; 189:297-308. (Pubitemid 44606742)
45. Almeida OP, Alfonso H, Pirkis J, et al. A practical approach to assess depression risk and to guide risk reduction strategies in later life. Int Psychogeriatr 2011; 23:280-291.
46. Smit F, Smits N, Schoevers R, et al. An epidemiological approach to depression prevention in old age. Am J Geriatr Psychiatry 2008; 16:444-453.